Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer (Q35354010)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

based on heuristic

inferred from title

evasion of host immune response

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bennett MW

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

O'connell J

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

O'sullivan GC

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Roche D

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Brady C

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Kelly J

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Collins JK

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Shanahan F

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

156-162

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Gene transfer of Fas ligand induces tumor regression in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Inhibition of the alloantibody response by CD95 ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

The Fas counterattack: a molecular mechanism of tumor immune privilege

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Human lung carcinomas express Fas ligand.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

The Fas death factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Fas ligand mediates activation-induced cell death in human T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

12 July 2018

The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727385

26 September 2018

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for CD95 ligand in preventing graft rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effect of locally produced CD95 ligand

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FasL--too much of a good thing? Transplanted grafts of pancreatic islet cells engineered to express Fas ligand are destroyed not protected by the immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/9895372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.44.2.156

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35354010&oldid=1580450857"